Close
CDMO Safety Testing 2026
Novotech

American Regent Recalls Batch of Calcium Gluconate Injections

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Sigma Healthcare Pursues Potential Boots Acquisition Deal

Australiaโ€™s Sigma Healthcare has confirmed that it is participating...

MHRA Launches AI Sandbox to Accelerate Drug Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has...

Pfizer’s Hympavzi Wins FDA Expanded Approval for Haemophilia A and B

Pfizer has secured an expanded indication approval from the...
- Advertisement -

American Regent has initiated a voluntary nationwide recall of a batch of calcium gluconate injections due to the presence of silicone particulates.The recall affects lot number 1,006 of calcium gluconate injection, USP, 10%, 100mL. American Regent has distributed the injections, manufactured by Luitpold Pharmaceuticals, to wholesalers and distributors nationwide.Calcium gluconate is indicated to treat conditions such as hypocalcaemic tetany or hypocalcaemia, to relieve muscle cramping due to black widow spider bites, rickets, osteomalacia, lead colic and magnesium sulphate overdoses.The injection has also been employed to decrease capillary permeability in allergic conditions, non-thrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs.In hyperkalaemia, calcium gluconate may aid in antagonising the cardiac toxicity provided the patient is not receiving digitalis therapy.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Sigma Healthcare Pursues Potential Boots Acquisition Deal

Australiaโ€™s Sigma Healthcare has confirmed that it is participating...

MHRA Launches AI Sandbox to Accelerate Drug Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has...

Pfizer’s Hympavzi Wins FDA Expanded Approval for Haemophilia A and B

Pfizer has secured an expanded indication approval from the...

Incyte Expands Haematology Portfolio with Vega Acquisition

Incyte has agreed to acquire Vega Therapeutics, a subsidiary...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป